MedTrace Logo

Hysterectomy for Benign Gynaecological Conditions With or Without Tubectomy

NCT02281487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2017-05-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether a tubectomy during hysterectomy for benign gynaecological conditions does not result into a premature menopause.

Conditions

  • Abdominal Hysterectomy (& Wertheim)

Interventions

PROCEDURE

Hysterectomy plus Tubectomy

hysterectomy with tubectomy

PROCEDURE

Hysterectomy

standard hysterectomy

DEVICE

light microscopy

analysis of the incidence of dysplastic lesions (defined as: nuclear atypia, pilling of epithelial cells, multiple mitosis), if any, in the removed Fallopian tubes by light microscopy (Leica DM4000)

Sponsors & Collaborators

  • Elisabeth-TweeSteden Ziekenhuis

    collaborator OTHER

  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER

  • Radboud University Medical Center

    collaborator OTHER

  • Jeroen Bosch Ziekenhuis

    collaborator OTHER

  • Gynaecologisch Oncologisch Centrum Zuid

    lead OTHER

Principal Investigators

  • Jurgen M Piek, MD. PhD. · Gynaecologisch Oncologisch Centrum Zuid

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
36 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-04-30
Completion
2016-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02281487 on ClinicalTrials.gov